These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10887512)

  • 21. Basal and therapy-driven hypoxia-inducible factor-1α confers resistance to endocrine therapy in estrogen receptor-positive breast cancer.
    Jia X; Hong Q; Lei L; Li D; Li J; Mo M; Wang Y; Shao Z; Shen Z; Cheng J; Liu G
    Oncotarget; 2015 Apr; 6(11):8648-62. PubMed ID: 25929338
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Steroid hormone receptors as targets for the therapy of breast and prostate cancer--recent advances, mechanisms of resistance, and new approaches.
    Hoffmann J; Sommer A
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):191-200. PubMed ID: 15860262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel estrogenic action of the pesticide residue beta-hexachlorocyclohexane in human breast cancer cells.
    Steinmetz R; Young PC; Caperell-Grant A; Gize EA; Madhukar BV; Ben-Jonathan N; Bigsby RM
    Cancer Res; 1996 Dec; 56(23):5403-9. PubMed ID: 8968093
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Recent progress of endocrine therapy in breast cancer].
    Nomura Y
    Gan To Kagaku Ryoho; 1992 Jun; 19(6):783-9. PubMed ID: 1605654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A sequential treatment regimen with melatonin and all-trans retinoic acid induces apoptosis in MCF-7 tumour cells.
    Eck KM; Yuan L; Duffy L; Ram PT; Ayettey S; Chen I; Cohn CS; Reed JC; Hill SM
    Br J Cancer; 1998 Jun; 77(12):2129-37. PubMed ID: 9649124
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of estrogen independence of ZR-75-1 human breast cancer cells by epigenetic alterations.
    van Agthoven T; van Agthoven TL; Dekker A; Foekens JA; Dorssers LC
    Mol Endocrinol; 1994 Nov; 8(11):1474-83. PubMed ID: 7533260
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanisms of tamoxifen resistance in the treatment of advanced breast cancer.
    Lykkesfeldt AE
    Acta Oncol; 1996; 35 Suppl 5():9-14. PubMed ID: 9142958
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ionizing radiation-mediated premature senescence and paracrine interactions with cancer cells enhance the expression of syndecan 1 in human breast stromal fibroblasts: the role of TGF-β.
    Liakou E; Mavrogonatou E; Pratsinis H; Rizou S; Evangelou K; Panagiotou PN; Karamanos NK; Gorgoulis VG; Kletsas D
    Aging (Albany NY); 2016 Aug; 8(8):1650-69. PubMed ID: 27434331
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The regulation of estrogen receptor expression and function in human breast cancer.
    Ferguson AT; Lapidus RG; Davidson NE
    Cancer Treat Res; 1998; 94():255-78. PubMed ID: 9587692
    [No Abstract]   [Full Text] [Related]  

  • 30. 17-Beta-estradiol inhibits transforming growth factor-beta signaling and function in breast cancer cells via activation of extracellular signal-regulated kinase through the G protein-coupled receptor 30.
    Kleuser B; Malek D; Gust R; Pertz HH; Potteck H
    Mol Pharmacol; 2008 Dec; 74(6):1533-43. PubMed ID: 18768737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Paradoxical regulation of estrogen-dependent growth factor gene expression in estrogen receptor (ER)-negative human breast cancer cells stably expressing ER.
    Jeng MH; Jiang SY; Jordan VC
    Cancer Lett; 1994 Jul; 82(2):123-8. PubMed ID: 8050081
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of growth factors, growth-inhibiting factors, and their receptors in invasive breast cancer. II: Correlations with proliferation and angiogenesis.
    de Jong JS; van Diest PJ; van der Valk P; Baak JP
    J Pathol; 1998 Jan; 184(1):53-7. PubMed ID: 9582527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between tamoxifen-induced transforming growth factor beta 1 expression, cytostasis and apoptosis in human breast cancer cells.
    Perry RR; Kang Y; Greaves BR
    Br J Cancer; 1995 Dec; 72(6):1441-6. PubMed ID: 8519657
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Absence of transforming growth factor-beta responsiveness in the tamoxifen growth-inhibited human breast cancer cell line CAMA-1.
    Ji H; Stout LE; Zhang Q; Zhang R; Leung HT; Leung BS
    J Cell Biochem; 1994 Mar; 54(3):332-42. PubMed ID: 8200913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transforming growth factors in human breast cancer.
    Salomon DS; Ciardiello F; Valverius E; Saeki T; Kim N
    Biomed Pharmacother; 1989; 43(9):661-7. PubMed ID: 2624883
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence that transforming growth factor-beta is a hormonally regulated negative growth factor in human breast cancer cells.
    Knabbe C; Lippman ME; Wakefield LM; Flanders KC; Kasid A; Derynck R; Dickson RB
    Cell; 1987 Feb; 48(3):417-28. PubMed ID: 2879636
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Growth regulatory peptide production by human breast carcinoma cells.
    Lippman ME; Dickson RB; Gelmann EP; Rosen N; Knabbe C; Bates S; Bronzert D; Huff K; Kasid A
    J Steroid Biochem; 1988; 30(1-6):53-61. PubMed ID: 3290584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TGF-beta signaling in breast cancer.
    Buck MB; Knabbe C
    Ann N Y Acad Sci; 2006 Nov; 1089():119-26. PubMed ID: 17261761
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanisms of endocrine resistance and novel therapeutic strategies in breast cancer.
    Normanno N; Di Maio M; De Maio E; De Luca A; de Matteis A; Giordano A; Perrone F;
    Endocr Relat Cancer; 2005 Dec; 12(4):721-47. PubMed ID: 16322319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Defects of TGF-beta receptor signaling in mammary cell tumorigenesis.
    Brattain MG; Ko Y; Banerji SS; Wu G; Willson JK
    J Mammary Gland Biol Neoplasia; 1996 Oct; 1(4):365-72. PubMed ID: 10887510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.